Targeted therapy for squamous cell lung cancer. - Wikidata - wikimedia - TriplyDB

Targeted therapy for squamous cell lung cancer.

Targeted therapy for squamous cell lung cancer.

http://www.wikidata.org/entity/Q37096910

about

Anticancer potential of Thevetia peruviana fruit methanolic extract.A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor.Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer.Squamous Cell Cancers: A Unified Perspective on Biology and Genetics Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer.Targeting FGFR in Squamous Cell Carcinoma of the Lung.Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCC FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.Next-generation molecular therapy in lung cancer.[Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].

P2860

Q33630033-05442368-0D15-4026-A36A-F7FB2B79A124 Q35798191-9CB3FCCE-185C-4FAB-A114-9E7FA917526B Q36389868-2DF3E6CB-7C17-4426-B667-8871CCC4DB97 Q36909843-8816A25C-52B0-44D1-95DD-380B8BCFC282 Q37699384-6B2D5342-DB9C-4009-957B-0DF40E8B931C Q38690050-48B8B67B-E93E-43A0-BA89-A9BAB27A7921 Q38693861-E43B5272-A79C-4115-B825-FADC30D0864A Q38802689-F1AE5364-B74F-43BF-9C11-72B60FEF2857 Q48360381-82084816-13BA-4890-BF99-3E9867636466 Q55142306-D1A46C60-50AC-48D4-BA06-B0BE3322CEF1 Q55443707-14A27BC3-7835-47D1-980D-4B2725489457

P2860

Targeted therapy for squamous cell lung cancer.

http://www.wikidata.org/entity/Q37096910

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeted therapy for squamous cell lung cancer.

@en

Targeted therapy for squamous cell lung cancer.

@nl

type

label

Targeted therapy for squamous cell lung cancer.

@en

Targeted therapy for squamous cell lung cancer.

@nl

prefLabel

Targeted therapy for squamous cell lung cancer.

@en

Targeted therapy for squamous cell lung cancer.

@nl

P1433

Q37096910-AF4AF788-FF62-4BCE-B158-FABDC205A4A3

P1476

Q37096910-7287403F-8098-4601-909E-7A6F65383D3F

P2093

Q37096910-05B0506E-E7F6-4607-8EF5-70C56074DDAD

Q37096910-D1F9ADF0-4747-478F-B74D-71BFFDABA7B0

Q37096910-DDA6DA54-103A-4625-A212-D5E54307933B

P2860

Q37096910-0BDCD83D-0A1D-489E-8E5A-F8FFEBA06690

Q37096910-0F68C305-6217-40AD-BE5E-C92312952E36

Q37096910-11F2EA96-744D-4E44-9B8B-0B7FB33D2150

Q37096910-139F3618-23AF-4338-83DF-6ACC045C4E2E

Q37096910-1A3578FC-6493-4CF1-9D3B-9928ED0E043B

Q37096910-25EAFA74-09CF-4C0A-9701-9615EF40C255

Q37096910-276E9610-694C-4844-9672-727F00E2FD24

Q37096910-29D5F1BD-E7A1-4BB1-8C58-66480F7077BC

Q37096910-2D19E314-AAA9-4048-831F-F15BD9F6667C

Q37096910-2E40BE3F-0EF7-436C-836F-7F7C7962A135

P304

Q37096910-AB0362D4-6310-4F1C-BA97-9E5E65372924

P31

Q37096910-2937FD53-D049-42C6-A4D1-7DBB15A54959

P356

Q37096910-44D992B1-005A-4965-9C5A-9C11E5427B53

P433

Q37096910-0F35883D-85C9-465A-9A05-A1D4E3678EA8

P478

Q37096910-A5B1F7DD-F714-4E7E-8CD0-C6743F68BB54

P50

Q37096910-3EB17D77-1B12-4BD0-BE4A-B0011155E83A

P577

Q37096910-AF396C5B-A915-4790-B395-F75B64A3350C

P698

Q37096910-28377E91-0C78-4563-9913-D2551657B783

P932

Q37096910-010A648D-33F5-4850-920C-3003ABB56A1A

P356

P1433

Lung cancer management

P1476

Targeted therapy for squamous cell lung cancer.

@en

P2093

Hideo Watanabe

http://www.w3.org/2001/XMLSchema#string

Peter S Hammerman

http://www.w3.org/2001/XMLSchema#string

Rachel G Liao

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.

P304

293-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/LMT.12.40

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Matthew Meyerson

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23956794

http://www.w3.org/2001/XMLSchema#string

P932

3744181

http://www.w3.org/2001/XMLSchema#string